| Literature DB >> 31724509 |
Biancamaria Longoni1, Irene Fasciani2, Shivakumar Kolachalam1, Ilaria Pietrantoni2, Francesco Marampon3, Francesco Petragnano2, Gabriella Aloisi2, Maria F Coppolino2, Mario Rossi4, Marco Scarselli1, Roberto Maggio2.
Abstract
Exosomes are extracellular vesicles produced by eukaryotic cells that are also found in most biological fluids and tissues. While they were initially thought to act as compartments for removal of cellular debris, they are now recognized as important tools for cell-to-cell communication and for the transfer of pathogens between the cells. They have attracted particular interest in neurodegenerative diseases for their potential role in transferring prion-like proteins between neurons, and in Parkinson's disease (PD), they have been shown to spread oligomers of α-synuclein in the brain accelerating the progression of this pathology. A potential neuroprotective role of exosomes has also been equally proposed in PD as they could limit the toxicity of α-synuclein by clearing them out of the cells. Exosomes have also attracted considerable attention for use as drug vehicles. Being nonimmunogenic in nature, they provide an unprecedented opportunity to enhance the delivery of incorporated drugs to target cells. In this review, we discuss current knowledge about the potential neurotoxic and neuroprotective role of exosomes and their potential application as drug delivery systems in PD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Exosomes; Parkinson’s disease; biomarkers; blood-brain barrier; dopaminergic neurons; drug delivery.
Mesh:
Substances:
Year: 2019 PMID: 31724509 DOI: 10.2174/1381612825666191113103537
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116